<?xml version="1.0" encoding="UTF-8"?>
<p>UFT/PSK immunochemotherapy was also ineffective or even unfavorable in the 1-year randomized phase III trial performed by Okuno et al. [
 <xref rid="B78-ijms-22-00634" ref-type="bibr">78</xref>] compared to surgery alone in 111 phase II colorectal cancer patients. Overall survival values were fairly similar in the two groups, while DFS was even worse in the treated group, although not statistically significant.
</p>
